SunRISe-5: A Phase 3, Randomized, Open-Label Study of TAR-200 Compared With Intravesical Chemotherapy After Bacillus Calmette–Guérin in Recurrent High-Risk Non–Muscle-Invasive …
Society of Urologic Oncology - SUNRISE-5: A PHASE 3, …
SunRISe-5 (NCT06211764) is a randomized, open-label, multicenter phase 3 study that evaluates the safety and efficacy of TAR-200 compared with investigator’s choice of intravesical …
SUO 2024: SunRISe-5: A Phase III, Randomized, Open-label Study …
SunRISe-5 (NCT06211764) is a randomized, open-label, multicenter phase III trial that is evaluating the safety and efficacy of TAR-200 compared with investigator’s choice of …
A Study of TAR-200 Versus Intravesical Chemotherapy in ... - Janssen
2025年1月11日 · A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus …
SunRISe-5 (NCT06211764) is a randomized, open-label, multicenter phase 3 study that evaluates the safety and efficacy of TAR-200 compared with intravesical chemotherapy in patients with …
TAR-200 and Mitomycin C and Gemcitabine in Non-Muscle
2024年1月9日 · A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus …
About the Phase 3 SunRISe-5 Study of TAR-200
2024年5月6日 · About the Phase 3 SunRISe-5 Study of TAR-200 | TargetedOnc.com | May 06, 2024
SunRISe-5 Trial: Evaluating TAR-200 for Recurrent High-Risk
2024年6月18日 · Sima Porten provides an overview of the SunRISe-5 trial, a Phase III study evaluating TAR-200, a novel drug delivery system for patients with recurrent high-risk non …
• SunRISe-5 is a randomized, open-label, multicenter phase 3 study evaluating the safety and efficacy of TAR-200 versus intravesical chemotherapy in patients with papillary-only HR …
SunRISe-5 - Health Research Authority
This is a Phase 3, randomised, open-label, active-controlled, multi-centre study evaluating the efficacy and safety of an investigational drug delivery system (TAR-200) when compared to …